JSPR

Jasper Therapeutics (JSPR)

Jasper Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:JSPR

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/06	06 : 52	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/03/06	06 : 02	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/03/04	21 : 40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/02/21	09 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/02/21	09 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/02/10	10 : 36	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/02/06	23 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/02/02	23 : 50	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/01/04	20 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2024/01/02	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/12/20	20 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/11/21	07 : 11	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/11/10	06 : 01	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/11/09	23 : 18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/11/09	22 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/11/01	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/10/20	19 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/10/14	07 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/10/10	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/10/10	19 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/09/25	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/09/21	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/08/12	05 : 39	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/08/12	05 : 06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/08/12	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/06/21	19 : 00	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/06/21	19 : 00	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/06/21	05 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/06/09	07 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JSPR	Jasper Therapeutics Inc
2023/06/09	07 : 44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:JSPR	Jasper Therapeutics Inc